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Control of coronavirus disease 2019 (COVID-19) heavily relies on universal access to testing in order to identify who is infected; track 
them to make sure they do not spread the disease further; and trace those with whom they have been in contact. The recent surge in 
COVID-19 cases in Zimbabwe is an urgent national public health concern and requires coordinated efforts to scale up testing using the 
capacity already in existence in the country. There is a need for substantial decentralization of testing, investment in better working condi-
tions for frontline health workers, and the implementation of measures to curb corruption within government structures.
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Coronavirus disease 2019 (COVID-19), caused by infection 
with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), was first identified in Wuhan City, Hubei Province, 
China, in December 2019 [1]. The disease has now spread to 
216 countries and territories around the world, with over 22.5 
million confirmed cases and over 790  000 deaths globally as 
of 19 August 2020 [1]. COVID-19 symptoms, which usually 
appear 2–14 days after exposure to the virus, include fever or 
chills, dry cough, tiredness, shortness of breath, and sometimes 
dyspnea [1]. Reverse transcription polymerase chain reaction 
(RT-PCR) is the gold standard for a laboratory diagnosis of 
SARS-CoV-2 infection [2].
Zimbabwe has not been spared by COVID-19. The first 
COVID-19 case in Zimbabwe was reported on 21 March in the 
resort town of Victoria Falls [3]. By 31 March, 7 more people 
had tested positive, with 1 reported death [3]. There was a steady 
increase in the number of cases in the months of April to July. 
In August, a surge in cases was reported, rising from 3659 on 
1 August 2020 to 5378 on 18 August 2020 [3]. As of 18 August 
2020, there were 141 reported COVID-19–related deaths [3]. 
Figure  1 presents the COVID-19 attack rate in Zimbabwean 
provinces. As illustrated in the map, there has been an uneven 
spread of the virus in Zimbabwe, and the Harare, Bulawayo, 
and Matebeleland South provinces are currently the COVID-19 
hotspots in the country.
Various mitigation strategies have been put in place, including 
a 3-week Phase 4 (total) lockdown from the end of March to mid-
April. Following the Phase 4 lockdown; the country entered a 
Phase 2 lockdown with relaxed restrictions. This resulted in ac-
celerated transmission, as prevention behavior slackened [4]. In 
response, on 23 July, the government increased lockdown restric-
tions, including by introducing a dusk-to-dawn curfew. Further 
mitigation strategies include strides to increase the testing ca-
pacity, training health workers on COVID-19 patient care, and 
increasing the number of quarantine and isolation centers through 
authorization of some private facilities [4].
Testing is an important strategy to contain or slow the pro-
gression of the pandemic in society [5]. The early detection of 
SARS-CoV-2 in infected people is important for limiting the 
transmission through isolation of cases, contact tracing, and 
quarantine of contacts [1]. Currently in Zimbabwe, testing is 
supposed to be done on suspect cases as per the World Health 
Organization (WHO) case definition, and contacts of con-
firmed cases and further patients should be identified through 
respiratory disease surveillance [4]. However, testing has been 
prioritized for people with a risk of developing severe disease, 
symptomatic health workers, and the first symptomatic indi-
viduals in a new area or new cluster where no cases have been 
reported previously [4]. There is an urgent need to scale-up 
COVID-19 testing to meet the current capacity and to ensure 
equal and equitable testing availability to all who want and/or 
need it.
Fear of stigma and discrimination and labeling are deterring 
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the unknown and hesitance of coping with isolation, should an 
individual test positive [8]. In the context of this novel virus, the 
content of COVID-19 information education communication 
(IEC) material is also rapidly evolving, as clinical symptoms of 
the disease and the various mitigatory and containment meas-
ures are updated. IEC on the benefits of testing [9] and associ-
ated counseling is minimal.
CURRENT COVID-19 TESTING CAPACITY IN 
ZIMBABWE
A precise analysis of COVID-19 in Africa, as a continent, con-
tinues to be hindered by limited testing and reporting of cases. 
The wide variance in the testing capacity, commitment to testing, 
and reporting of COVID-19 cases and deaths means those coun-
tries that are undertaking the most tests or reporting the highest 
number of cases may not necessarily be those countries most im-
pacted or at risk from the pandemic [10]. In Zimbabwe, the testing 
of the SARS-CoV-2 virus has evolved over time. Trained medical 
laboratory scientists and technicians perform COVID-19 testing in 
Zimbabwe. Training on testing is provided by Ministry of Health 
and Child Care, supported by various organizations, such as the 
WHO and the Africa Centres for Disease Control and Prevention, 
among others. The country follows the WHO guidelines on testing 
[11]. Initially, confirmatory PCR testing was done at the National 
Institute of Communicable Diseases in South Africa [4]. Over 
time, laboratory support for PCR tests was extended to 5 public 
laboratories in the country that had existing platforms for human 
immunodeficiency virus (HIV) testing, and to date multiple other 
districts’ provincial and private laboratories have been authorized 
to test for the SARS-CoV-2 virus. Provinces are showing marked 
differences in their COVID-19 testing levels, and although there 
is a high density of testing sites in the current COVID-19 hotspots 
like Harare and Bulawayo, the testing capacity of these provinces 
in relation to their population density is rather low (Figure  2), 
whereas Matabeleland North and South had the largest testing ca-
pacity in relation to their population density.
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Testing has been done in the form of rapid antibody testing 
and PCR testing. Rapid antibody testing has been used as a 
screening test at the borders and workplaces, whereas PCR 
has been used as a diagnostic test for all symptomatic people, 
hospitalized patients, and people who are positive with rapid 
antibody testing. As of 18 August 2020, a total of 84 741 PCR 
tests have been done [3]. The testing sites have employed var-
ious molecular platforms, with the district and provincial la-
boratories mostly relying on GeneXpert (Cepheid) analyzers. 
Table 1 presents the distribution of PCR platforms and assays, 
with an account of the throughput if assuming an 8-hour work 
shift. Combined, the laboratories have a capacity of 9658 PCR 
tests daily. As of 18 August 2020, the country is conducting an 
average of 1200 diagnostic PCR tests per day [3]. This available 
data for Zimbabwe shows inadequate testing levels that do not 
meet the current capacity. The WHO issued a warning of a “si-
lent epidemic” to African governments, calling for testing to be 
prioritized and to be delivered on a much greater scale than it is 
at the moment [12]. The next section discusses barriers to wide-
spread COVID-19 testing in Zimbabwe, focusing on procure-
ment, health system funding, health workforces, and standards 
at quarantine facilities.
BARRIERS TO WIDESPREAD COVID-19 TESTING IN 
ZIMBABWE
Procurement and Supply Chain–Related Issues
Figure  3 shows the trend of COVID-19 tests conducted and 
the reported number of PCR-positive cases since March 2020. 
There was a steady increase in the number of tests conducted 
in March, with a peak at the end of April. This trend has been 
due in part to persistent challenges with the procurement and 
supply chain of COVID-19 test kits [13]. A shortage of reagents 
and consumables, among them Gene Xpert cartridges, naso-
pharyngeal swabs, Viral Load Transport medium, and other 
reagents for PCR testing, has hampered COVID-19 testing 
in Zimbabwe. This has severely impacted the testing capacity, 







niversity of the W
estern C
ape user on 31 August 2021
e670 • cid 2021:72 (15 May) • VIEWPOINTS
leading to high turnaround of results, thereby impacting ser-
vice delivery. The global demand for the kits and reagents has 
seen manufacturing countries prioritize their homelands [14, 
15]. According to Médecins Sans Frontiers research, diag-
nostics company Cepheid is charging 4 times more than it 
should for its COVID-19 tests [16]. Cepheid has set the price 
for each test at $19.80 in 145 developing countries, including 
Zimbabwe, when the tests could be sold at a profit for $5 each 
[16]. Given that the majority of testing sites in Zimbabwe rely 
on the Cepheid platform for COVID-19 testing [4], the cost 
per kit may also deter widespread testing for private facilities 
that purchase their own test kits. Further, it is worth noting 
that the closure of borders and grounding of most cargo ships 
and flights also had adverse impact on importing the kits to 
Zimbabwe. Corruption in procurement of COVID-19 reagents 
has also emerged, resulting in some tenders being cancelled, 
further delaying the procurement process [17]. This also brings 
into disrepute the credibility of the government in handling 
donor funds, thus derailing or even stopping some donations 
that may have been earmarked for the country.
Health System Funding-related Issues
Another important major barrier to widespread COVID-19 
testing in Zimbabwe has been the chronically underfunded 
health system. The testing has relied on donors from Jack Ma, 
The United States Centers for Disease Control and Prevention, 
and other partners [18] who have made substantial contribu-
tions to the effort to boost the COVID-19 testing in Zimbabwe. 
In the early phases of the pandemic, sample transportation was 
a major challenge [7]; consequently, the Ministry of Health 
and Child Care (MoHCC), in collaboration with its partners, 
put in place a transport system that leverages an existing HIV 
program to ferry samples to the laboratories. However, in a 
country with severe shortages of fuel, the challenge of sample 
transport persists in some areas.
Health Worker–Related Issues
Zimbabwe has also experienced a “brain drain,” as more 
skilled medical laboratory scientists have continued to 
evade district and provincial hospitals in favor of better 
working conditions in neighboring and overseas countries 
Table 1. Coronavirus Disease 2019 Testing Facilities in Zimbabwe and 8-Hour Platform Throughput
Province Facility name Molecular platform/assay 8-hour shift throughput
Harare National Microbiology Reference Laboratory Abbott Real Time SARS-CoV-2 Assay 376
QuantStudio 3 Real-time PCR System 276
National Virology Reference Laboratory Applied Biosystems 7500 200
Parirenyatwa Central Hospital Cepheid Gene Xpert 32
African Institute of Biomedical Science  
and Technology
Applied Biosystems 7500 276
Premier Clinical Laboratories AccuPower SARS-CoV-2 Real-time RT-PCR  
Kit (Bioneer)
96
CIMAS Cepheid Gene Xpert 32
Biomedical Research Training Institute QuantStudio 3 Real-time PCR System 276
Lancet AccuPower SARS-CoV-2 Real-time RT-PCR  
Kit (Bioneer)
96
Manicaland Mutare Provincial Hospital Cepheid Gene Xpert 32
Abbott Real Time SARS-CoV-2 Assay 376
Mashonaland Central Bindura Provincial Hospital Cepheid Gene Xpert 32
Mashonaland East Chikurubi Prisons Cepheid Gene Xpert 32
Marondera Provincial Hospital Cepheid Gene Xpert 32
Kadoma General Hospital Cepheid Gene Xpert 32
Mashonaland West Chinhoyi Provincial Hospital Cepheid Gene Xpert 32
Masvingo Masvingo Provincial Hospital Cepheid Gene Xpert 32
Matebeleland North Victoria Falls Hospital Cepheid Gene Xpert 32
St Luke’s Hospital Cepheid Gene Xpert 32
Abbott Real Time SARS-CoV-2 Assay 188
Hwange Colliery Hospital Cepheid Gene Xpert 32
Matebeleland South Beitbridge Hospital Cepheid Gene Xpert 32
Gwanda Hospital Cepheid Gene Xpert 32
Abbott Real Time SARS-CoV-2 Assay 188
Plumtree Hospital Cepheid Gene Xpert 32
Midlands Gweru Provincial Hospital Cepheid Gene Xpert 32
Bulawayo Thorngroove Infectious Disease Hospital Cepheid Gene Xpert 32
National Tuberculosis Reference Laboratory QuantStudio 3 Real-time PCR System 276
Diagnostic laboratory Services Gentier 48s Real Time PCR 48
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Figure 3. Trend in number of COVID-19 tests conducted and reported PCR positives as of 19 July 2020 (source: MoHCC Zimbabwe [3]). Abbreviations: COVID-19, corona-
virus disease 2019; MoHCC, Ministry of Health and Child Care; PCR, polymerase chain reaction.
[19]. According to the Health Services Board, 64% of med-
ical laboratory scientist positions in public laboratories 
were vacant as of December 2019 [20]. This implies that 
even most laboratories may not meet their daily capacity, 
because there aren’t enough people there to prepare and 
process the samples. Further, this also negatively impacts 
the quality of testing in the public laboratories, which 
have been left to be manned by less skilled cadres. The 
government-employed nurses and doctors have been on 
strike due to low remuneration, coupled with salaries that 
are continuously eroded by hyperinflation.
A new threat has emerged, with a surge in the number of 
health workers testing positive for SARS-CoV-2. As of 28 July, 
323 health workers had tested positive for SARS-CoV-2 [21]. 
The subsequent isolation of the confirmed cases and quarantine 
of those colleagues who have been in close contact with con-
firmed cases has reduced the number of health workers available 
to serve patients [22].
The health workers have also reported a lack of the personal 
protective equipment (PPE) that is essential for discharging 
their duties, especially during this COVID-19 crisis [7, 23]. 
The strike, low morale, and quarantines of the infected health 
workers are causing increased fatigue among the few health 
workers, thereby compromising the quality of service.
Quarantine Facilities–Related Issues
The country initially experienced a significant number of im-
ported cases from neighboring South Africa through both 
designated and undesignated ports of entry [3]. The undes-
ignated port of entry has presented a major challenge, as the 
people using these ports of entry are not documented and 
tested before they interact with other people in the society [24]. 
Even for those individuals who followed the right procedures 
for entry into the country, cases of individuals escaping from 
the quarantine centers have been reported [25]. There is a 
growing body of evidence that calls for quarantine centers to 
scale up provision of proper counselling, support, and treat-
ment to the returnees [8, 26]. When people are well informed 
and knowledgeable about the merits of the whole process, 
they are more likely to comply. A  joint team comprised of 
MoHCC, the International Organization for Migration, and 
the WHO assessed the suitability and appropriateness of 
37 quarantine facilities across the country during the period of 
17–21 May 2020. The assessment revealed a lack of guidance 
of how the facilities should be operating [27]. In some facil-
ities, roles and responsibilities were not clearly defined [27]. 
The occupants were not practicing maximum safety measures 
to avoid or limit transmission within the facilities [27]. There 
was no guidance on infection prevention and control (IPC) 
issues at the facilities, and PPEs were in short supply [27]. 
There is an urgent need to train quarantine staff on COVID-
19, ensure safety and maintenance of hygiene, provide reg-
ular screening and testing of quarantine staff, develop and 
distribute standard operating procedures and guidelines for 
IPC at the quarantine facility, and procure and provide ad-
equate supplies required for IPC [28]. Currently, COVID-19 
diagnostic testing is mandatory at Day 8 of quarantine [28]. 
There is need to consider COVID-19 testing upon arrival at 
the quarantine site. Recently, local cases have also been on 
the increase, and beginning in July the number has surpassed 
imported cases [3]. This is an illustration that the pandemic 
has moved into a profile which is localized, and therefore this 
has an implication on testing targets and patterns. Further, 
this trend underscores the need to continuously engage the 
community [29, 30] to adhere to various containment and 
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RECOMMENDATIONS TO IMPROVE COVID-19 
TESTING LEVELS TO MEET THE CAPACITY IN 
ZIMBABWE
Political Will and Resource Allocation
As the outbreak accelerates in the country, the call to ramp 
up COVID-19 testing to meet the current capacity in order to 
better control the pandemic cannot be overemphasized. To rap-
idly improve testing capacity, there is a need for provision of ad-
equate resources [31], coupled with motivated health workers. 
Political will plays an important role in ensuring that testing ca-
pacity is increased, as decisions will be made at the highest level 
and implemented cascading downwards. In this regard, domestic 
rechanneling of resources from other line ministries to health will 
be crucial, as external aid support is likely to diminish.
Protect Health Workers
Since the inception of the pandemic, the government has recruited 
additional health workers and introduced a COVID-19 allowance. 
While the government has made efforts to reshuffle staff around 
clinics to focus on those facilities with the highest COVID-19–re-
lated workloads, there is a need for the development of programs for 
periodic debriefing and burnout prevention for frontline workers. 
Frontline health workers who are testers also need psychosocial 
support, especially if they are witnessing increased positive rates of 
testing or if they are witnessing highly distressed patients at the time 
of testing [32]. Dealing with the anxiety of frontline health workers 
is just as important as dealing with client anxieties. The government 
may also consider stepping up efforts to reengage skilled health 
workers who have moved to other sectors of work, to ease the strain 
on the core health-care complement.
Utilize Available Regional Procurement Platforms
There is a need for better coordination in the procurement 
of COVID-19 test kits [31]. The recent launch of the Africa 
Medical Supplies Platform is promising. The platform un-
locks immediate access to an African and global base of vetted 
manufacturers and procurement strategic partners, and enables 
African Union Member States to purchase certified medical 
equipment, such as diagnostic kits, PPE, and clinical manage-
ment devices, with increased cost effectiveness and transpar-
ency. This platform, coupled with the African Continental Free 
Trade Area facility, has the potential to reduce the cost of re-
agents and improve the supply chain process.
Leverage Existing Infrastructure and Resources While Exploring Cost-
saving Test Approaches
Zimbabwe is a recipient of important financial support for the HIV 
pandemic, and these resources can be leveraged in the COVID-19 
response. The United States government’s substantial HIV-related 
investments in Zimbabwe have also focused on laboratory infra-
structure [33, 34]. The US government has employed a 2-pronged 
approach. First, it has provided support to the national laboratory 
capacity focused on HIV viral load testing and provided Quality 
Assurance and Quality Control (QA/QC) programs through its 
laboratory-focused implementation partners. Second, its HIV sur-
veillance focused support to the MoHCC through the Zimbabwe 
Population-Based HIV Impact Assessment (ZIMPHIA) 2015–16 
and ZIMPHIA2020 projects [35]. These 2 projects have upgraded 
the infrastructure at MoHCC laboratories, trained laboratory sci-
entists, and provided equipment to facilities. Finally, Zimbabwe is 
also a recipient of a grant of approximately US$5 million from the 
United Kingdom Department of Health and Social Care, under 
its Fleming Fund Grants Programme to support national medical 
laboratory capacity [36]. The grant is enhancing the country’s lab-
oratory capacity for disease surveillance, increasing QA/QC, pro-
viding equipment, and renovating laboratory infrastructures [36]. 
All these donor investments could be leveraged further to improve 
COVID-19 testing levels. However, the diversion of financial re-
sources, particularly from HIV and tuberculosis (TB) programs, 
should be done carefully, as disruption to HIV and TB testing may 
potentially have greater impacts on morbidity and mortality than 
COVID-19 in the Zimbabwean context. Given that Cepheid XPert 
machines are used throughout much of the country for TB testing, 
the country could benefit from using a single platform like Xpert 
for COVID-19 testing, and using economy of scale to cut costs on 
procurement of both the platforms and the reagents.
Address Issues of Corruption in the Health System
There is a need to urgently address issues of graft that have been 
reported in the procurement process [37]. In the context of the 
COVID-19 pandemic, civil society organizations (CSOs) can play 
an important role in demanding enhanced transparency and good 
governance in Zimbabwe by contributing to increased public de-
bate on issues surrounding the formulation and implementation of 
COVID-19 financial resources. CSOs and development partners 
need to adopt creative means to track, monitor, and shadow report 
on disparities and anomalies that emerge in resource and com-
modity utilization, on a frequent basis. The Zimbabwean COVID-
19 response could benefit from CSOs’ cooperation with national 
and international human rights agencies [38] and donors, to guide 
the effective tracking and shadow reporting. CSOs can also be en-
gaged to support testing efforts in motivating and mobilizing com-
munities to take up COVID-19 testing.
Increase Testing Through Community Interventions
There is a need for a sustainable scale-up to ensure commu-
nity literacy is increased, and to mobilize acceptance of testing 
[9]. IEC dissemination, preferably in vernacular languages, 
should be available via radio, TV, and digital social media plat-
forms. In the context of quarantines of returnees, wide access 
to COVID-19 IEC dissemination is fundamental to remove 
any stigma against returnees, which has the potential to cause 
an underground divide, with a likelihood of ultimately coun-
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health workers to ensure proper pre- and posttest counseling is 
offered, both to the persons being tested and their families, to 
alleviate anxiety and deter self-stigma or external stigma and 
discrimination [39].
COVID-19 Pooled Testing for Cohesive Groups
We recommend that Zimbabwe embrace pooled testing [40] for 
cohesive groups, such as health-care workers. This approach is 
particularly useful in these groups, where a single positive typ-
ically requires quarantine of the entire group. Pooled testing 
has also been shown to be useful among asymptomatic and 
presymptomatic COVID-19 patients, who are an important 
source of transmission [40].
CONCLUSION
Zimbabwe’s limited testing capacity has been mainly due to 
inadequate investment by its government, over the years, to 
the health system. The government must increase its own fi-
nancial investment in the response to COVID-19 and not be 
solely dependent on international donors. The recent surge 
in COVID-19 cases is an urgent public health concern and 
requires coordinated efforts to ramp up testing to meet the 
capacity already in existence in the country. There is a need 
for substantial decentralization of testing from the current 
provincial level to the district level. Zimbabwe needs to in-
vest in better salaries and working conditions for its frontline 
health workers, and decisively deal with graft within its 
structures.
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